Visit-to-visit systolic blood pressure variability predicts all-cause and cardiovascular mortality after lacunar infarct

European Journal of Neurology

Volumn 21, Issue 2, 2014, Pages 319-325

  Lau, K K ^a   Wong, Y K ^a   Chang, R S K ^a   Teo, K C ^a   Hon, S F K ^a   Chan, K H ^a   Wat, K L ^a   Cheung, R T F ^a   Li, L S W ^a   Siu, C W ^a   Ho, S L ^a   Tse, H F ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Blood pressure variability; Lacunar infarct; Mortality

Indexed keywords

ACUTE CORONARY SYNDROME; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; CORONARY RISK; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; SYSTOLIC BLOOD PRESSURE; VERY ELDERLY;

BLOOD PRESSURE VARIABILITY; LACUNAR INFARCT; MORTALITY;

AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; STROKE, LACUNAR;

EID: 84892478243     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12310     Document Type: Article

References (27)

1. Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375: 895-905.
2. Muntner P, Shimbo D, Tonelli M, et al. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension 2011; 57: 160-166.
3. Poortvliet RK, Ford I, Lloyd SM, et al. Blood pressure variability and cardiovascular risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). PLoS ONE 2012; 7: e52438.
4. Hata Y, Muratani H, Kimura Y, et al. Office blood pressure variability as a predictor of acute myocardial infarction in elderly patients receiving antihypertensive therapy. J Hum Hypertens 2002; 16: 141-146.
5. Suchy-Dicey AM, Wallace ER, Mitchell SV, et al. Blood pressure variability and the risk of all-cause mortality, incident myocardial infarction, and incident stroke in the Cardiovascular Health Study. Am J Hypertens 2013; 26: 1210-1217.
6. Conway J, Boon N, Davies C, et al. Neural and humoral mechanisms involved in blood pressure variability. J Hypertens 1984; 2: 203-208.
7. Mancia G, Parati G, Pomidossi G, et al. Arterial baroreflexes and blood pressure and heart rate variabilities in humans. Hypertension 1986; 8: 147-153.
8. Sega R, Cesana G, Bombelli M, et al. Seasonal variations in home and ambulatory blood pressure in the PAMELA population. Pressione Arteriose Monitorate E Loro Associazioni. J Hypertens 1998; 16: 1585-1592.
9. Okada H, Fukui M, Tanaka M, et al. Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes. Atherosclerosis 2012; 220: 155-159.
10. Kang J, Ko Y, Park JH, et al. Effect of blood pressure on 3-month functional outcome in the subacute stage of ischemic stroke. Neurology 2012; 79: 2018-2024.
11. Endo K, Kario K, Koga M, et al. Impact of early blood pressure variability on stroke outcomes after thrombolysis: the SAMURAI rt-PA Registry. Stroke 2013; 44: 816-818.
12. Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44: 2064-2089.
13. Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and management of blood-pressure variability. Nat Rev Cardiol 2013; 10: 143-155.
14. Wu B, Lin S, Hao Z, et al. Proportion, risk factors and outcome of lacunar infarction: a hospital-based study in a Chinese population. Cerebrovasc Dis 2010; 29: 181-187.
15. Yamamoto Y, Akiguchi I, Oiwa K, et al. Adverse effect of nighttime blood pressure on the outcome of lacunar infarct patients. Stroke 1998; 29: 570-576.
16. Liu W, Liu R, Sun W, et al. Different impacts of blood pressure variability on the progression of cerebral microbleeds and white matter lesions. Stroke 2012; 43: 2916-2922.
17. Masugata H, Senda S, Murao K, et al. Visit-to-visit variability in blood pressure over a 1-year period is a marker of left ventricular diastolic dysfunction in treated hypertensive patients. Hypertens Res 2011; 34: 846-850.
18. Nagai M, Hoshide S, Ishikawa J, et al. Visit-to-visit blood pressure variations: new independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease. J Am Soc Hypertens 2011; 5: 184-192.
19. Kawai T, Ohishi M, Kamide K, et al. The impact of visit-to-visit variability in blood pressure on renal function. Hypertens Res 2012; 35: 239-243.
20. Hsieh YT, Tu ST, Cho TJ, et al. Visit-to-visit variability in blood pressure strongly predicts all-cause mortality in patients with type 2 diabetes: a 5.5-year prospective analysis. Eur J Clin Invest 2012; 42: 245-253.
21. Eguchi K, Hoshide S, Schwartz JE, et al. Visit-to-visit and ambulatory blood pressure variability as predictors of incident cardiovascular events in patients with hypertension. Am J Hypertens 2012; 25: 962-968.
22. Hata Y, Kimura Y, Muratani H, et al. Office blood pressure variability as a predictor of brain infarction in elderly hypertensive patients. Hypertens Res 2000; 23: 553-560.
23. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42: 227-276.
24. Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet 2010; 375: 906-915.
25. Webb AJ, Rothwell PM. Effect of dose and combination of antihypertensives on interindividual blood pressure variability: a systematic review. Stroke 2011; 42: 2860-2865.
26. Ichihara A, Kaneshiro Y, Sakoda M, et al. Add-on amlodipine improves arterial function and structure in hypertensive patients treated with an angiotensin receptor blocker. J Cardiovasc Pharmacol 2007; 49: 161-166.
27. Xie HH, Miao CY, Jiang YY, Su DF. Synergism of atenolol and nitrendipine on hemodynamic amelioration and organ protection in hypertensive rats. J Hypertens 2005; 23: 193-201.